FWHC Holdings, LLC 13D and 13G filings for H-CYTE, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-25 4:05 pm Purchase | 2022-02-23 | 13D | H-CYTE, Inc. HCYT | FWHC Holdings, LLC | 697,263 67.740% | 42,302 (+6.46%) | Filing |
| 2021-03-11 06:04 am Sale | 2020-09-24 | 13D | H-CYTE, Inc. HCYT | FWHC Holdings, LLC | 654,961 68.700% | -18,560 (-2.76%) | Filing |
| 2020-09-30 8:09 pm Purchase | 2020-09-24 | 13D | H-CYTE, Inc. HCYT | FWHC Holdings, LLC | 673,521 69.410% | 24,255 (+3.74%) | Filing |
| 2020-07-10 4:13 pm Purchase | 2020-07-06 | 13D | H-CYTE, Inc. HCYT | FWHC Holdings, LLC | 649,265 69.680% | 619,926 (+2112.94%) | Filing |
| 2020-05-20 4:40 pm Unchanged | 2020-04-17 | 13D | H-CYTE, Inc. HCYT | FWHC Holdings, LLC | 29,340 22.700% | 0 (Unchanged) | Filing |
| 2020-02-25 4:10 pm Purchase | 2019-11-15 | 13D | H-CYTE, Inc. HCYT | FWHC Holdings, LLC | 29,340 22.800% | 29,340 (New Position) | Filing |